{
    "Trade/Device Name(s)": [
        "ARCHITECT\u00ae DHEA-S Calibrators (A-F)",
        "ARCHITECT\u00ae DHEA-S Controls (Low, Medium, High)"
    ],
    "Submitter Information": "Biokit S.A.",
    "510(k) Number": "K060027",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "January 26, 2006",
    "Summary Letter Received Date": "January 4, 2006",
    "Submission Date": "December 27, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Calibrator, Secondary",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Dehydroepiandrosterone sulfate (DHEA-S)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent Microparticle Immunoassay (CMIA)",
        "Competitive assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT\u00ae DHEA-S Calibrators and Controls for calibration and quality control of DHEA-S determination on the ARCHITECT i System.",
    "Indications for Use Summary": "For calibration and verification of accuracy and precision of the ARCHITECT i System in the quantitative determination of DHEA-S in human serum and plasma.",
    "fda_folder": "Clinical Chemistry"
}